Figure 3
Figure 3. Identification of a novel variant in FOXP3 associated with IPEX syndrome. (A) Sequence of the FOXP3 gene in the IPEX patient. (B) FOXP3 expression in Tregs (CD4+CD25hi) and Tnaive (CD4+CD25−) from the IPEX patient and healthy control shown by flow cytometry (left) and histogram the mean fluorescence intensity (right). (C) In vitro suppression assay using Tregs from a healthy control or IPEX patient and carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled allogeneic responder T cells.

Identification of a novel variant in FOXP3 associated with IPEX syndrome. (A) Sequence of the FOXP3 gene in the IPEX patient. (B) FOXP3 expression in Tregs (CD4+CD25hi) and Tnaive (CD4+CD25) from the IPEX patient and healthy control shown by flow cytometry (left) and histogram the mean fluorescence intensity (right). (C) In vitro suppression assay using Tregs from a healthy control or IPEX patient and carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled allogeneic responder T cells.

Close Modal

or Create an Account

Close Modal
Close Modal